CLINICAL_TRIALS
trial_result
· 2016-12-07
Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes [Phase 3]
Summary
Phase 3 trial update for dulaglutide in adults with type 2 diabetes; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2016-12-07